Hikma Pharmaceuticals Pink Sheet Forward View - Accumulation Distribution
| HKMPF Stock | USD 20.69 1.61 7.22% |
Hikma Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Hikma Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 8th of February 2026 the relative strength index (rsi) of Hikma Pharmaceuticals' share price is below 20 . This usually indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Hikma Pharmaceuticals hype-based prediction, you can estimate the value of Hikma Pharmaceuticals PLC from the perspective of Hikma Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Hikma Pharmaceuticals after-hype prediction price | USD 20.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Hikma |
Hikma Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Hikma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hikma using various technical indicators. When you analyze Hikma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Hikma Pharmaceuticals Volatility | Backtest Hikma Pharmaceuticals | Information Ratio |
Hikma Pharmaceuticals Trading Date Momentum
| On February 08 2026 Hikma Pharmaceuticals PLC was traded for 20.69 at the closing time. The highest daily price throughout the period was 20.69 and the lowest price was 20.69 . There was no trading activity during the period 0.0. Lack of trading volume on 02/08/2026 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Hikma Pharmaceuticals to competition |
Other Forecasting Options for Hikma Pharmaceuticals
For every potential investor in Hikma, whether a beginner or expert, Hikma Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hikma Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hikma. Basic forecasting techniques help filter out the noise by identifying Hikma Pharmaceuticals' price trends.Hikma Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hikma Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Hikma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hikma Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Hikma Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Hikma Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hikma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Hikma Pharmaceuticals pink sheet market strength indicators, traders can identify Hikma Pharmaceuticals PLC entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 20.69 | |||
| Day Typical Price | 20.69 | |||
| Price Action Indicator | (0.80) | |||
| Period Momentum Indicator | (1.61) |
Hikma Pharmaceuticals Risk Indicators
The analysis of Hikma Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Hikma Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hikma pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.9212 | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.52 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Hikma Pharmaceuticals
The number of cover stories for Hikma Pharmaceuticals depends on current market conditions and Hikma Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hikma Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hikma Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Hikma Pink Sheet
Hikma Pharmaceuticals financial ratios help investors to determine whether Hikma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hikma with respect to the benefits of owning Hikma Pharmaceuticals security.